[1]
2024. Comparative Utility of Doxorubicin, Cyclophosphamide, and Docetaxel in Breast Cancer Treatment in West Sumatera. Pharmaceutical and Biomedical Sciences Journal (PBSJ). 6, 2 (Dec. 2024), 152–160. DOI:https://doi.org/10.15408/pbsj.v6i2.40914.